A single center, open-label, fixed-sequence, pharmacokinetics and pharmacodynamics drug-drug interaction study of Esuberaprost (BPS-314d-MR) and warfarin in healthy adult subjects
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Esuberaprost (Primary) ; Warfarin (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacodynamics; Pharmacokinetics
- 23 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society